Trade AstraZeneca PLC - GBP - AZNl CFD

Add to favourite

113.68

1.68%

1.20

Low: 112.88

High: 114.2

Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Fri: 08:00 - 12:00 12:03 - 16:30

Summary
Historical Data

Trading сonditions

Spread

1.20

Long position overnight fee

-0.023255%

Short position overnight fee

0.001338%

Overnight fee time

21:00 (UTC)

Min traded quantity

0.1

Currency

GBP

Margin

5.00%

Stock exchange

United Kingdom of Great Britain and Northern Ireland

Commission on trade

Key Stats

Prev. Close	111.8
Open	113.02
1-Year Change	5.42%
Day's Range	112.88 - 114.2

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Mar 28, 2025	113.68	1.60	1.43%	112.08	114.30	110.90
Mar 27, 2025	111.80	0.20	0.18%	111.60	112.30	110.96
Mar 26, 2025	112.24	-0.72	-0.64%	112.96	113.30	110.90
Mar 25, 2025	112.22	-0.02	-0.02%	112.24	115.62	111.20
Mar 24, 2025	114.52	-0.92	-0.80%	115.44	116.14	113.20
Mar 21, 2025	115.80	-2.14	-1.81%	117.94	118.00	115.80
Mar 20, 2025	117.76	2.44	2.12%	115.32	118.62	115.32
Mar 19, 2025	118.04	0.24	0.20%	117.80	118.94	117.56
Mar 18, 2025	118.42	1.70	1.46%	116.72	119.64	116.72
Mar 17, 2025	118.92	-1.49	-1.24%	120.41	120.63	117.70
Mar 14, 2025	119.41	0.95	0.80%	118.46	120.05	118.38
Mar 13, 2025	118.72	2.12	1.82%	116.60	118.86	114.28
Mar 12, 2025	114.10	-0.70	-0.61%	114.80	116.60	114.10
Mar 11, 2025	114.10	-3.04	-2.60%	117.14	118.24	114.10
Mar 10, 2025	118.48	0.22	0.19%	118.26	119.30	116.28
Mar 7, 2025	117.90	-1.68	-1.40%	119.58	120.55	117.32
Mar 6, 2025	117.92	-1.57	-1.31%	119.49	120.39	117.92
Mar 5, 2025	119.59	0.22	0.18%	119.37	120.65	117.92
Mar 4, 2025	118.94	0.02	0.02%	118.92	121.29	118.92
Mar 3, 2025	119.09	-0.49	-0.41%	119.58	120.01	116.82

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

AstraZeneca - GBP Company profile

About AstraZeneca plc

AstraZeneca PLC (AstraZeneca) is a patient-focused biopharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines, primarily for the treatment of diseases. The Company is focused on three main therapy areas: Oncology; Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development. The Company has access to technologies, both internally and through its various collaborations. Its technologies include acoustic tube technology, advanced molecular imaging, cryo-electron microscopy (cryo-EM), functional genomics, multi-omics and AstraZeneca iLab. The Company’s acoustic tube technology helps it to handle and process millions of compounds for biological screening. Its AstraZeneca iLab is its prototype of an automated medicinal chemistry laboratory.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, AstraZeneca plc revenues increased 41% to $37.42B. Net income decreased 96% to $112M. Revenues reflect Farxiga segment increase of 53% to $3B, Calquenc segment increase from $522M to $1.24B, Tagrisso segment increase of 16% to $5.02B, United States segment increase of 35% to $12.05B, United Kingdom segment increase of 86% to $3.25B, Sweden segment increase from $1.03B to $2.32B.

Industry:

Pharmaceuticals (NEC)

1 Francis Crick Avenue
CAMBRIDGE
CAMBRIDGESHIRE CB2 0AA
GB